{"database": "openregs", "table": "documents", "rows": [["FDA-2016-D-4308-0012", "FDA", "FDA-2016-D-4308", "10 Reference 9 FDA Guidance for Industry For the Submission of Chemistry Manufacturing and Controls and Establishment Description Information for Human Blood and Blood Components Intended for Transfusion re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2017-01-03T05:00:00Z", 2017, 1, null, null, "2017-01-03T15:14:09Z", null, 0, 0, "0900006482446f1f"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2016-D-4308-0012"], "units": {}, "query_ms": 0.44525100383907557, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}